Search Legislation

Commission Decision of 26 November 2009 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2010 and following years (notified under document C(2009) 9131) (2009/883/EC)

 Help about what version

What Version

 Help about opening options

Opening Options

More Resources

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version

CHAPTER II MULTI-ANNUAL PROGRAMMES

Article 13Rabies

1.The multi-annual programmes for the eradication of rabies submitted by Lithuania and Austria are hereby approved for the period from 1 January 2010 to 31 December 2012.

2.The third year of the multi-annual programmes for the eradication of rabies submitted by Estonia, Latvia, Slovenia, and Finland are hereby approved for the period from 1 January 2010 to 31 December 2010.

3.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the characterisation of rabies virus, the detection of biomarker, age determination and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes and shall not exceed:

(a)EUR 950 000 for Estonia;

(b)EUR 1 130 000 for Latvia;

(c)EUR 1 000 000 for Lithuania;

(d)EUR 110 000 for Austria

(e)EUR 550 000 for Slovenia;

(f)EUR 100 000 for Finland.

4.The maximum of the costs to be reimbursed to the concerned Member State for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for an ELISA test

EUR 8 per test;

(b) for a test to detect tetracycline in bone

EUR 8 per test;

(c) for a fluorescent antibody test (FAT)

EUR 12 per test.

5.The amounts to be committed for the following years shall be decided in function of the execution of the programme in 2010.

Article 14Aujeszky’s disease

1.The third year of the multi-annual programme for the eradication of Aujeszky’s disease submitted by Belgium is hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the cost to be incurred by Belgium of carrying out laboratory tests and shall not exceed EUR 262 000.

3.The maximum of the costs to be reimbursed to Belgium for the programme referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 1 per test.

Article 15Enzootic bovine leucosis

1.The second year of the multi-annual programmes for the eradication of enzootic bovine leucosis submitted by Italy, Latvia, and Portugal is hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes and shall not exceed:

(a)EUR 800 000 for Italy;

(b)EUR 55 000 for Latvia;

(c)EUR 750 000 for Portugal.

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for an ELISA test

EUR 0,5 per test;

(b) for an agar gel immune diffusion test

EUR 0,5 per test;

(c) for animals slaughtered

EUR 375 per animal.

Article 16Scrapie

1.The second year of the multi-annual programme for the monitoring and eradication of scrapie submitted by Cyprus on 18 March 2009 is hereby approved for the period from 1 January 2010 to 31 December 2010.

2.The financial contribution by the Community shall not exceed EUR 8 200 000 and shall be at the rate of:

(a)100 % of the costs to be incurred by Cyprus for carrying out rapid tests referred to in Annex III Chapter A Part II points 1 to 5 to Regulation (EC) No 999/2001 and Annex VII thereto and primary molecular discriminatory tests as referred to in Annex X Chapter C point 3.2(c)(i) to Regulation (EC) No 999/2001;

(b)75 % of the cost incurred by Cyprus for the compensation to owners for the value of their animals culled and destroyed in accordance with its programme for monitoring and eradication of scrapie;

(c)50 % of the costs of:

(i)

the analysis of samples for genotyping;

(ii)

the purchase of preparations used for euthanizing the animals;

(iii)

personnel specifically hired for carrying out tasks within the programme;

(iv)

destruction of the carcasses.

3.The maximum of the costs to be reimbursed to Cyprus for the programme referred to in paragraph 1 shall on average not exceed:

(a) for tests carried out in ovine and caprine animals

EUR 30 per test;

(b) for primary molecular discriminatory tests carried out

EUR 175 per test;

(c) for genotyping tests

EUR 10 per test;

(d) for culled sheep or goats

EUR 100 per animal.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources